These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Laboratory decontamination and destruction of carcinogens in laboratory wastes: some antineoplastic agents. International Agency for Research on Cancer. IARC Sci Publ; 1985; (73):1-162. PubMed ID: 3015793 [No Abstract] [Full Text] [Related]
3. Stability and inactivation of mutagenic drugs and their metabolites in the urine of patients administered antineoplastic therapy. Monteith DK; Connor TH; Benvenuto JA; Fairchild EJ; Theiss JC Environ Mol Mutagen; 1987; 10(4):341-56. PubMed ID: 3315656 [TBL] [Abstract][Full Text] [Related]
4. Chemical degradation of wastes of antineoplastic agents: cyclophosphamide, ifosfamide and melphalan. Hansel S; Castegnaro M; Sportouch MH; De Méo M; Milhavet JC; Laget M; Duménil G Int Arch Occup Environ Health; 1997; 69(2):109-14. PubMed ID: 9001917 [TBL] [Abstract][Full Text] [Related]
5. Degradation and disposal of some antineoplastic drugs. Lunn G; Sansone EB; Andrews AW; Hellwig LC J Pharm Sci; 1989 Aug; 78(8):652-9. PubMed ID: 2550609 [TBL] [Abstract][Full Text] [Related]
6. Chemical degradation of wastes of antineoplastic agents. 2: Six anthracyclines: idarubicin, doxorubicin, epirubicin, pirarubicin, aclarubicin, and daunorubicin. Castegnaro M; De Méo M; Laget M; Michelon J; Garren L; Sportouch MH; Hansel S Int Arch Occup Environ Health; 1997; 70(6):378-84. PubMed ID: 9439983 [TBL] [Abstract][Full Text] [Related]
7. Destruction of some polycyclic heterocyclic compounds using oxidation by potassium permanganate in alkaline solution. Castegnaro M; Barek J; De Meo M; Laget M IARC Sci Publ; 1991; (114):9-15. PubMed ID: 8690471 [No Abstract] [Full Text] [Related]
8. Evaluation of decontamination efficacy of cleaning solutions on stainless steel and glass surfaces contaminated by 10 antineoplastic agents. Queruau Lamerie T; Nussbaumer S; Décaudin B; Fleury-Souverain S; Goossens JF; Bonnabry P; Odou P Ann Occup Hyg; 2013 May; 57(4):456-69. PubMed ID: 23223271 [TBL] [Abstract][Full Text] [Related]
9. Study on the Use of Ozone Water as a Chemical Decontamination Agent for Antineoplastic Drugs in Clinical Settings. Kato G; Mitome H; Teshima K; Tawa K; Hakuba Y; Tanabe T; Funahashi T; Hatae N; Koike Y; Hasebe M; Hidaka N; Tanaka M; Akira K Ann Work Expo Health; 2023 Feb; 67(2):241-251. PubMed ID: 36416483 [TBL] [Abstract][Full Text] [Related]
10. Testing the degradation effects of three reagents on various antineoplastic compounds. Gohma H; Inoue Y; Asano M; Sugiura S J Oncol Pharm Pract; 2015 Aug; 21(4):268-73. PubMed ID: 24727343 [TBL] [Abstract][Full Text] [Related]
11. Destruction of aromatic amines in laboratory wastes through oxidation with potassium permanganate/sulfuric acid into non-mutagenic derivatives. Castegnaro M; Malaveille C; Brouet I; Michelon J; Barek J Am Ind Hyg Assoc J; 1985 Apr; 46(4):187-91. PubMed ID: 4003269 [TBL] [Abstract][Full Text] [Related]
12. Destruction of some polycyclic heterocyclic compounds using oxidation by potassium permanganate. Barek J; Castegnaro M; Michelon J; De Meo M; Laget M IARC Sci Publ; 1991; (114):17-23. PubMed ID: 8690468 [No Abstract] [Full Text] [Related]
13. Oxidative destruction of hydrazines produces N-nitrosamines and other mutagenic species. Castegnaro M; Brouet I; Michelon J; Lunn G; Sansone EB Am Ind Hyg Assoc J; 1986 Jun; 47(6):360-4. PubMed ID: 3739905 [TBL] [Abstract][Full Text] [Related]
14. Safe decontamination of cytostatics from the nitrogen mustards family. Part one: cyclophosphamide and ifosfamide. Štenglová Netíková IR; Petruželka L; Šťastný M; Štengl V Int J Nanomedicine; 2018; 13():7971-7985. PubMed ID: 30538471 [TBL] [Abstract][Full Text] [Related]
15. Decontamination methods for cytotoxic drugs. 1. Use of a bioluminescent technique to monitor the inactivation of methotrexate with chlorine-based agents. Wren AE; Melia CD; Garner ST; Denyer SP J Clin Pharm Ther; 1993 Apr; 18(2):133-7. PubMed ID: 8458881 [TBL] [Abstract][Full Text] [Related]
16. Procedures for destruction of patulin in laboratory wastes. Frémy JM; Castegnaro MJ; Gleizes E; De Meo M; Laget M Food Addit Contam; 1995; 12(3):331-6. PubMed ID: 7664923 [TBL] [Abstract][Full Text] [Related]
17. Studies on the pharmacokinetics and metabolism of cis-dichloro-trans-dihydroxy-bis-isopropylamine platinum(IV) in the dog. Pendyala L; Cowens JW; Creaven PJ Cancer Treat Rep; 1982 Mar; 66(3):509-16. PubMed ID: 7060038 [TBL] [Abstract][Full Text] [Related]
18. Laboratory decontamination and destruction of aflatoxins B1, B2, G1, G2 in laboratory wastes. Castegnaro M; Hunt DC; Sansone EB; Schuller PL; Siriwardana MG; Telling GM; Van Egmond HP; Walker EA IARC Sci Publ; 1980; (37):1-59. PubMed ID: 6783518 [No Abstract] [Full Text] [Related]
19. Stability and compatibility of antitumor agents in glass and plastic containers. Benvenuto JA; Anderson RW; Kerkof K; Smith RG; Loo TL Am J Hosp Pharm; 1981 Dec; 38(12):1914-8. PubMed ID: 7325172 [TBL] [Abstract][Full Text] [Related]
20. Identification of cis-dichloro-bis-isopropylamine platinum(II) as a major metabolite of iproplatin in humans. Pendyala L; Cowens JW; Chheda GB; Dutta SP; Creaven PJ Cancer Res; 1988 Jun; 48(12):3533-6. PubMed ID: 3370646 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]